Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Thematic (Sector/Industry)

<ul><li class="p1">Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value reimbursement and slowing advancements weigh on the traditional large joint replacement market.</li><li class="p1">In particular, we think the extremities market— representing 50% of projected incremental orthopedic sales from 2015–2020—is an important growth avenue that has not been carefully examined by the investment community.</li></ul>Analyst: Debbie Wang

Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value reimbursement and slowing advancements weigh on the traditional large joint replacement market.In particular, we think the extremities market— representing 50% of projected incremental orthopedic sales from 2015–2020—is an important growth avenue that has not been carefully examined by the investment community.Analyst: Debbie Wang

Healthcare Observer: Orthopedic Innovation Beyond Large Joint Market Fuels Long-Term Growth

M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

Event-Driven

The U.S. Congress has pushed legislation to amend the present nature of U.S. antitrust reviews by barring one of the two U.S. antitrust enforcement agencies, the Federal Trade Commission,&nbsp;from proceeding with its own internal&nbsp;administrative hearing once a federal court has denied a preliminary injunction in a particular deal.

The U.S. Congress has pushed legislation to amend the present nature of U.S. antitrust reviews by barring one of the two U.S. antitrust enforcement agencies, the Federal Trade Commission,&nbsp;from proceeding with its own internal&nbsp;administrative hearing once a federal court has denied a preliminary injunction in a particular deal.

Bill Would Bar Second FTC Chance to Block Mergers

Information Technology Consultant

Ishita Jain

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that focuses on making the mundane chore of keeping fit into a&nbsp;joyful and inspiring activity. With 45&nbsp;studios and 300,000 unique riders across the US, the company has grown from strength to strength and is seen as a 'movement' rather than an emerging brand. It runs cycle studios,&nbsp;set in a dark, candlelit room to high-energy music, where&nbsp;riders move in unison and follow the cues and choreography of the instructor.Now,&nbsp;SoulCycle is going&nbsp;public and hoping to raise up to $100 million via an IPO. While the prospectus is littered with super-charged words describing a&nbsp;revolutionary fitness&nbsp;ecosystem, does it have enough substance to hook investors much like its elitist&nbsp;clientele?&nbsp;

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that focuses on making the mundane chore of keeping fit into a&nbsp;joyful and inspiring activity. With 45&nbsp;studios and 300,000 unique riders across the US, the company has grown from strength to strength and is seen as a 'movement' rather than an emerging brand. It runs cycle studios,&nbsp;set in a dark, candlelit room to high-energy music, where&nbsp;riders move in unison and follow the cues and choreography of the instructor.Now,&nbsp;SoulCycle is going&nbsp;public and hoping to raise up to $100 million via an IPO. While the prospectus is littered with super-charged words describing a&nbsp;revolutionary fitness&nbsp;ecosystem, does it have enough substance to hook investors much like its elitist&nbsp;clientele?&nbsp;

SoulCycle IPO - Good for your portfolio and your soul?

Macro Strategist, Saxo Capital Markets

Kay Van-Petersen

Macro Strategist

Saxo Capital Markets

<ul><li>Another blow-up non-farm number coming up? Run US macro bears, run! &nbsp;</li><li>European equities will end up 30% to 60% for the year. Play through peripherals&nbsp;</li><li>Massive shift down in volatility; picking up options is cheaper than last week</li></ul>

Another blow-up non-farm number coming up? Run US macro bears, run! &nbsp;European equities will end up 30% to 60% for the year. Play through peripherals&nbsp;Massive shift down in volatility; picking up options is cheaper than last week

End-2015 should see Euro-zone EQ up +40-60%, Nikkei over 22K, USDCHF over 1.02, USDJPY over 125

<ul><li>Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central banker” will soon become mainstream.&nbsp; </li><li>In this piece, KVP takes a snap shot of what happened, the significance &amp; potential ways to look to play things going forward. </li></ul>

Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central banker” will soon become mainstream.&nbsp; In this piece, KVP takes a snap shot of what happened, the significance &amp; potential ways to look to play things going forward. 

United States

STERIS Public Limited Company operates as a provider of infection prevention and other procedural products and services. The Company offers sterilizers and washers, surgical tables, lights and equipment management systems, and endoscopy accessories. STERIS serves healthcare, pharmaceutical, and medical device industries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

STERIS (STE US)

Healthcare Observer: Orthopedic Innovation Beyond Large Joint Market Fuels Long-Term Growth

Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value...

Morningstar, Inc.

Bill Would Bar Second FTC Chance to Block Mergers

The U.S. Congress has pushed legislation to amend the present nature of U.S. antitrust reviews by barring one of the two U.S. antitrust enforcement...

CTFN

SoulCycle IPO - Good for your portfolio and your soul?

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...

Ishita Jain

End-2015 should see Euro-zone EQ up +40-60%, Nikkei over 22K, USDCHF over 1.02, USDJPY over 125

Another blow-up non-farm number coming up? Run US macro bears, run! European equities will end up 30% to 60% for the year. Play through...

Kay Van-Petersen

Never Trust A Swiss Central Banker

Post SNB surprise announcement yesterday - after leading the market on as recently as a few weeks ago on – the term “Never trust a Swiss central...

Kay Van-Petersen

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)